Clinical trials
Phase 1 Medulloblastoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2010 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 4 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| Children's Oncology Group | 3 |
| C17 Council | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medulloblastoma | 11 |
| Astrocytoma | 6 |
| Oligodendroglioma | 5 |
| Optic Nerve Glioma | 5 |
| Rhabdoid Tumor | 5 |
| Central Nervous System Neoplasms | 4 |
| Choroid Plexus Neoplasms | 4 |
| Diffuse Intrinsic Pontine Glioma | 4 |
| Ependymoma | 3 |
| Glioma | 3 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.